Interchange Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Buy
+1,014
New +$251K 0.04% 388
2021
Q3
– Sell
-1,160
Closed -$206K – 103
2021
Q2
$206K Buy
+1,160
New +$201K 0.32% 94
2021
Q1
– Sell
-29
Closed -$4K – 682
2020
Q4
$4K Buy
+29
New +$4.32K ﹤0.01% 983

Other funds holding JAZZ

Interchange Capital Partners's JAZZ Position: Q3 2026 in Review

Interchange Capital Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 1,014 shares worth $235K. The stake represents 0.04% of the portfolio and ranks #388 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in JAZZ as recently as Q2 2021.

Interchange Capital Partners first reported a position in JAZZ in Q4 2020 and has held it in 3 quarters since. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Interchange Capital Partners held 1,014 shares of Jazz Pharmaceuticals worth $235K as of Q3 2026.
  • Jazz Pharmaceuticals was a new Interchange Capital Partners position in Q3 2026.
  • Jazz Pharmaceuticals made up 0.04% of Interchange Capital Partners's portfolio in Q3 2026, its #388 holding.
  • Interchange Capital Partners first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.